Research Catalog

Title

Control of the leishmaniases : report of a meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, 22-26 March 2010.

Author

WHO Expert Committee on the Control of the Leishmaniases. Meeting (2010 : Geneva)

Publication

Geneva : World Health Organization, 2010.

Items in the Library & Off-site

Details

Additional Authors

World Health Organization.

Description

xiii, 186 pages : illustrations, maps; 24 cm.

Summary

"This report makes recommendations on new therapeutic regimens for visceral and cutaneous leishmaniasis, on the use of rapid diagnostic tests, details on the management of Leishmania-HIV coinfection and consideration of social factors and climate change as risk factors for increased spread. Recommendations for research include the furtherance of epidemiological knowledge of the disease and clinical studies to address the lack of an evidence-based therapeutic regimen for cutaneous and mucocutaneous leishmaniasis and post-kala-azar dermal leishmaniasis (PKDL). This report not only provides clear guidance on implementation but should also raise awareness about the global burden of leishmaniasis and its neglect. It puts forward directions for formulation of national control programmes and elaborates the strategic approaches in the fight against the leishmaniases. The committee's work reflects the latest scientific and other relevant developments in the field of leishmaniasis that can be considered by Member States when setting national programmes and making public health decisions."--Page 4 of cover.

Series Statement

WHO technical report series, 0512-3054 ; 949

Uniform Title

Technical report series (World Health Organization) ; 949.

Subject

• Leishmaniasis > Congresses
• Leishmaniasis > Control > Congresses
• Leishmaniasis > prevention & control
• Leishmaniose
• Zoonose
• Maladies infectieuses
• Maladies tropicales
• SIDA = Syndrome immuno-déficitaire acquis
• Santé publique
• Contrôle sanitaire
• Congrès
• Leishmaniasis

Genre/Form

• Congress
• Conference papers and proceedings.
• Actes de congrès.

Bibliography (note)

• Includes bibliographical references.

Additional Formats (note)

• Also available in an electronic version.

Contents

• Machine generated contents note: 1. History -- 2. Leishmaniases in humans -- 2.1. Clinical forms -- 2.1.1. Old World visceral leishmaniasis -- 2.1.2. Old World cutaneous leishmaniasis -- 2.1.3. Old World mucosal leishmaniasis -- 2.1.4. Old World diffuse cutaneous leishmaniasis -- 2.1.5. New World visceral leishmaniasis -- 2.1.6. New World cutaneous leishmaniasis -- 2.1.7. New World mucocutaneous leishmaniasis -- 2.1.8. New World diffuse cutaneous leishmaniasis -- 2.1.9. Disseminated cutaneous leishmaniasis -- 2.1.10. Post-kala-azar dermal leishmaniasis -- 2.1.11. Leishmania and HIV coinfection -- 2.2. Pathology -- 2.2.1. General pathology -- 2.2.2. Visceral leishmaniasis -- 2.2.3. Post-kala-azar dermal leishmaniasis -- 2.2.4. Uncomplicated cutaneous leishmaniasis -- 2.2.5. Disseminated cutaneous leishmaniasis -- 2.2.6. Leishmaniasis recidivans -- 2.2.7. Diffuse cutaneous leishmaniasis -- 2.2.8. Mucocutaneous leishmaniasis.
• 2.3. Parasitology -- 2.3.1. Identification criteria -- 2.3.2. Reference strains -- 2.3.3. Identification methods -- 2.3.4. Taxonomy -- 2.4. Reservoir hosts -- 2.4.1. Definition -- 2.4.2. General aspects of reservoir capacity -- 2.4.3. Incrimination of reservoir hosts -- 2.4.4. Humans as reservoir hosts -- 2.4.5. Domestic and peridomestic reservoir hosts -- 2.4.6. Wild reservoir hosts of the Old World -- 2.4.7. Wild reservoir hosts of the New World -- 2.5. Vectors -- 2.5.1. Taxonomy -- 2.5.2. Identification criteria -- 2.5.3. Biology -- 2.5.4. Incrimination of vectors -- 2.5.5. Vector competence -- 2.6. Epidemiological aspects -- 2.6.1. Major foci and human behaviour -- 2.6.2. Socioeconomic factors -- 2.6.3. Malnutrition -- 2.6.4. Population movement -- 2.6.5. Environmental changes -- 2.6.6. Climate change -- 2.6.7. Periodic fluctuations in incidence of disease -- 2.6.8. Epidemiological research and mathematical models -- 2.6.9. Geographical information systems.
• 2.6.10. Epidemiological surveys of visceral leishmaniasis -- 3. Control -- 3.1. Diagnosis -- 3.1.1. Visceral leishmaniasis -- 3.1.2. Cutaneous leishmaniasis -- 3.1.3. Mucocutaneous leishmaniasis -- 3.1.4. Post-kala-azar dermal leishmaniasis -- 3.1.5. Coinfection with Leishmania and HIV -- 3.2. Treatment and vaccines -- 3.2.1. General considerations -- 3.2.2. Antileishmanial medicines -- 3.2.3. Treatment options -- 3.2.4. Special situations -- 3.2.5. Prophylactic leishmaniasis vaccines -- 3.2.6. Immunochemotherapy and therapeutic vaccines -- 3.3. Detection -- 3.3.1. Passive case detection -- 3.3.2. Active case detection -- 3.4. Control of reservoir hosts -- 3.4.1. Humans as reservoir hosts -- 3.4.2. Canine reservoir hosts -- 3.4.3. Wild animal reservoir hosts of Old World cutaneous leishmaniasis -- 3.4.4. Wild animal reservoir hosts of New World cutaneous leishmaniasis -- 3.5. Vector control -- 3.5.1. General considerations -- 3.5.2. Methods.
• 3.5.3. Entomological monitoring and evaluation of vector control operations -- 3.6. Epidemic response -- 3.6.1. Rapid assessment -- 3.6.2. Epidemic preparedness -- 3.6.3. Outbreak response -- 3.7. Socioeconomic aspects of leishmaniasis control -- 3.7.1. Social determinants of risk -- 3.7.2. Cost-effectiveness of control measures -- 3.7.3. Access to medicines and diagnostics -- 3.7.4. Public-private partnerships -- 4. Burden of leishmaniases -- 4.1. Geographical distribution by country -- 4.2. Estimated burden -- 5. Control strategies by nosogeographical entity -- 5.1. Visceral leishmaniasis caused by L. donovani and L. infantum (L. chagasi) -- 5.1.1. Visceral leishmaniasis caused by L. donovani on the Indian subcontinent -- 5.1.2. Visceral leishmaniasis in East Africa and the southwest Arabian peninsula caused by L. donovani and L. infantum -- 5.1.3. Visceral leishmaniasis caused by L. donovani in other places -- 5.1.4. Foci of visceral leishmaniasis caused by L. infantum with known or assumed canine reservoir hosts.
• 5.2. Anthroponotic cutaneous leishmaniasis caused by L. tropica -- 5.3. Sporadic cutaneous leishmaniasis caused by L. tropica and related species -- 5.4. Zoonotic cutaneous leishmaniasis caused by L. major -- 5.5. Zoonotic cutaneous leishmaniasis in the East African highlands caused by L. aethiopica -- 5.6. Cutaneous leishmaniasis caused by L. peruviana -- 5.7. Cutaneous leishmaniasis caused by L. guyanensis -- 5.8. Cutaneous and mucocutaneous leishmaniasis caused by L panamensis -- 5.9. Cutaneous and mucocutaneous leishmaniasis caused by L braziliensis -- 5.10. Cutaneous leishmaniasis caused by L. mexicana and related species -- 5.11. Cutaneous leishmaniasis caused by L. infantum -- 5.12. Cutaneous leishmaniasis caused by other New World species -- 6. Organization of control -- 6.1. Control of leishmaniasis as part of primary health care -- 6.1.1. Community participation -- 6.1.2. Social mobilization and communication -- 6.2. Definition of national plans -- 6.2.1. Purpose and implementation of national control programmes.
• 6.2.2. Collection of epidemiological data -- 6.2.3. Definition of control strategies and activities -- 6.2.4. Intersectoral coordination -- 6.2.5. Formal adoption of the national control strategy or plan -- 6.3. Surveillance -- 6.4. Pharmacovigilance -- 6.5. Monitoring and evaluation -- 7. International coordination -- 7.1. Reporting -- 7.2. Technical partners -- 7.3. Intercountry programmes for advocacy and awareness-raising -- 7.4. International standards -- 8. Health education and training -- 8.1. Health education -- 8.2. Training -- 9. Research -- 9.1. Field research -- 9.2. Laboratory research -- 9.3. Drug and vaccine research and development -- 9.3.1. What products are needed? -- 9.3.2. Challenges to the development and use of antileishmanial treatment -- 9.3.3. Input of other approaches -- 10. Recommendations.

ISBN

• 9789241209496
• 9241209496

LCCN

2011377311

OCLC

• ocn692290687
• 692290687
• SCSB-1591292

Owning Institutions

Princeton University Library